[go: up one dir, main page]

IL134691A0 - Compounds containing six-membered rings, processes for their preparation, and their use as medicaments - Google Patents

Compounds containing six-membered rings, processes for their preparation, and their use as medicaments

Info

Publication number
IL134691A0
IL134691A0 IL13469198A IL13469198A IL134691A0 IL 134691 A0 IL134691 A0 IL 134691A0 IL 13469198 A IL13469198 A IL 13469198A IL 13469198 A IL13469198 A IL 13469198A IL 134691 A0 IL134691 A0 IL 134691A0
Authority
IL
Israel
Prior art keywords
medicaments
processes
preparation
compounds containing
membered rings
Prior art date
Application number
IL13469198A
Original Assignee
Gilead Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gilead Sciences Inc filed Critical Gilead Sciences Inc
Publication of IL134691A0 publication Critical patent/IL134691A0/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/01Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/45Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • C07C233/52Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a ring other than a six-membered aromatic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/57Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C233/62Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/16Antivirals for RNA viruses for influenza or rhinoviruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/57Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C233/63Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/16Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to carbon atoms of rings other than six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/16Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL13469198A 1997-09-17 1998-09-15 Compounds containing six-membered rings, processes for their preparation, and their use as medicaments IL134691A0 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US5930897P 1997-09-17 1997-09-17
US6019597P 1997-09-26 1997-09-26
US93864497A 1997-09-26 1997-09-26
PCT/US1998/019355 WO1999014185A1 (en) 1997-09-17 1998-09-15 Compounds containing six-membered rings, processes for their preparation, and their use as medicaments

Publications (1)

Publication Number Publication Date
IL134691A0 true IL134691A0 (en) 2001-04-30

Family

ID=27369627

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13469198A IL134691A0 (en) 1997-09-17 1998-09-15 Compounds containing six-membered rings, processes for their preparation, and their use as medicaments

Country Status (15)

Country Link
EP (1) EP1015417A1 (en)
JP (1) JP2001516739A (en)
KR (1) KR20010024123A (en)
CN (1) CN1272105A (en)
AR (1) AR013960A1 (en)
AU (1) AU747702B2 (en)
BR (1) BR9812649A (en)
CA (1) CA2303323A1 (en)
EA (1) EA003989B1 (en)
ID (1) ID25516A (en)
IL (1) IL134691A0 (en)
IN (1) IN190983B (en)
NZ (1) NZ502988A (en)
TR (1) TR200000723T2 (en)
WO (1) WO1999014185A1 (en)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1040094T3 (en) * 1997-12-17 2009-06-02 Biocryst Pharm Inc Substituted cyclopentane and cyclopenten compounds useful as neuraminidase inhibitors
US6455571B1 (en) 1998-04-23 2002-09-24 Abbott Laboratories Inhibitors of neuraminidases
US6518305B1 (en) 1998-04-23 2003-02-11 Abbott Laboratories Five-membered carbocyclic and heterocyclic inhibitors of neuraminidases
DK1059283T3 (en) * 1999-06-11 2003-09-15 Hoffmann La Roche Process for the preparation of neuraminidase inhibitor ro-64-0796
US6593314B1 (en) 1999-10-19 2003-07-15 Abbott Laboratories Neuraminidase inhibitors
WO2001028981A1 (en) * 1999-10-19 2001-04-26 Abbott Laboratories 1-cyclohexene-1-carboxylic acid and 1-cyclohexene-1-carboxylates as neuraminidase inhibitors
JP2001131144A (en) 1999-11-02 2001-05-15 Sagami Chem Res Center Method for producing 7-azabicyclo [4.1.0] hept-3-en-3-carboxylic acid esters
US6403824B2 (en) * 2000-02-22 2002-06-11 Hoffmann-La Roche Inc. Process for the preparation for 4,5-diamino shikimic acid derivatives
AU2001252578A1 (en) * 2000-04-25 2001-11-07 Sankyo Company Limited Preventives for influenza
WO2002092555A1 (en) * 2001-05-11 2002-11-21 Sankyo Company, Limited Sialic acid derivatives
US7122684B2 (en) 2003-03-13 2006-10-17 Roche Colorado Corporation Process for preparing 1,2-diamino compounds
CA2633538A1 (en) * 2005-12-28 2007-07-05 F. Hoffmann-La Roche Ag Epoxide intermediate in the tamiflu synthesis
US8334319B2 (en) * 2008-01-04 2012-12-18 Roche Palo Alto Llc Polymorphic forms of oseltamivir phosphate
CN102597120B (en) * 2009-11-11 2015-05-27 3M创新有限公司 Polymer composition and its preparation method and article
DE102011117128A1 (en) 2011-10-28 2013-05-02 Christian-Albrechts-Universität Zu Kiel Compounds for the treatment of influenza
RU2469020C1 (en) * 2011-11-08 2012-12-10 Александр Васильевич Иващенко (3r,4r,5s)-4-acylamino-5-amino-3-(1-ethyl-propoxy)-cyclohex-1-ene-carboxylic acids, their esters and method for using
CN102659615B (en) * 2012-05-09 2014-05-07 中国药科大学 Derivatives of oseltamivir, and preparation method and medical application thereof
RU2520836C1 (en) * 2013-02-27 2014-06-27 Александр Васильевич Иващенко (3r,4r,5s)-4-amino-5-(2,2-difluoroacetylamino)-3-(1-ethylpropoxy)-cyclohex-1-enecarboxylic acid and its ethers, method of obtaining and applying thereof
RU2633085C2 (en) * 2014-05-20 2017-10-11 Российская Федерация, от имени которой выступает Федеральное государственное казенное учреждение "Войсковая часть 68240" Antiviral drug as capsules and method for its preparation
CN105439884A (en) * 2015-10-27 2016-03-30 沈阳药科大学 Oseltamivir preparation method
CN108047076B (en) * 2017-12-26 2020-05-08 杭州新博思生物医药有限公司 Preparation method of oseltamivir enantiomer
CN110194728B (en) * 2019-06-19 2021-04-30 湖南华腾制药有限公司 Continuous synthesis method of oseltamivir phosphate intermediate
CN114057599A (en) * 2020-07-29 2022-02-18 广州市恒诺康医药科技有限公司 Neuraminidase inhibitor compound, pharmaceutical composition and application thereof
CN116375595A (en) * 2023-03-31 2023-07-04 重庆医药高等专科学校 A kind of preparation method and refining method of oseltamivir phosphate
CN117105801A (en) * 2023-07-24 2023-11-24 四川青木制药有限公司 A kind of preparation method and intermediate of oseltamivir and its phosphate
CN116666669B (en) * 2023-07-25 2023-10-03 四川大学 VN-supported Ir clusters, their preparation methods and their use in catalysts

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ288492B6 (en) * 1990-04-24 2001-06-13 Biota Scient Management Derivatives of alpha-D-neuraminic acid, process of their preparation, their use and pharmaceutical preparations based thereon
WO1992006691A1 (en) * 1990-10-19 1992-04-30 Biota Scientific Management Pty. Ltd. Anti-viral compounds that bind the active site of influenza neuramidase and display in vivo activity against orthomyxovirus and paramyxovirus
CN100409844C (en) * 1995-02-27 2008-08-13 吉里德科学公司 neuraminidase inhibitors
US5763483A (en) * 1995-12-29 1998-06-09 Gilead Sciences, Inc. Carbocyclic compounds
ATE215062T1 (en) * 1996-08-23 2002-04-15 Gilead Sciences Inc METHOD FOR PRODUCING CYCLOHEXENE CARBOXYLATE DERIVATIVES

Also Published As

Publication number Publication date
JP2001516739A (en) 2001-10-02
BR9812649A (en) 2000-08-22
IN190983B (en) 2003-09-06
ID25516A (en) 2000-10-05
CN1272105A (en) 2000-11-01
EA003989B1 (en) 2003-12-25
AU747702B2 (en) 2002-05-16
NZ502988A (en) 2002-08-28
WO1999014185A1 (en) 1999-03-25
EP1015417A1 (en) 2000-07-05
TR200000723T2 (en) 2001-06-21
EA200000332A1 (en) 2000-10-30
AU9569498A (en) 1999-04-05
AR013960A1 (en) 2001-01-31
CA2303323A1 (en) 1999-03-25
KR20010024123A (en) 2001-03-26

Similar Documents

Publication Publication Date Title
IL134691A0 (en) Compounds containing six-membered rings, processes for their preparation, and their use as medicaments
HUP0003844A3 (en) Novel spiroazabicyclic heterocyclic compounds, process for their preparation, their use and pharmaceutical compositions containing them
HUP0004024A3 (en) Azabenzimidazole-based compounds, process for their preparation and pharmaceutical composition thereof
HUP0102556A3 (en) Benzenesulfonamide-derivatives and their use as medicaments and process for the preparation of the compounds
IL135920A0 (en) 2-aryl -8-oxodihydropurine derivative, process for the preparation thereof, pharmaceutical composition containing the same and intermediate therefor
HUP0001508A3 (en) 4-arylmethylene-2-imino-2,3-dihydrothiazole derivatives, their use, process for the preparation thereof and pharmaceutical compositions containing them
HUP0000068A3 (en) Process for producing ecteinascidin compounds, their use and pharmaceutical compositions containing them
HUP0002718A3 (en) Piperazine derivatives, process for their preparation and medicaments containing the same
HUP9701169A3 (en) Cycloalkano-pyridine derivatives, intermediates, preparation and use thereof, pharmaceutical compositions containing these compounds
HUP9700328A3 (en) Heteroaryl-oxazolidinones, process for their preparation, pharmaceutical compositions containing the same, their use and intermediates
IL148870A0 (en) 2'-substituted 1, 1'-biphenyl-2-carbonamides, method for the production thereof, use thereof as medicament and pharmaceutical preparations containing said compounds
HUP9900348A3 (en) New oxazolidinone derivatives, preparation and use thereof and medicaments containing these compounds
IL112443A0 (en) Heterocyclic compounds, their preparation and pharmaceutical compositions containing them
AU6062498A (en) Propanolamine derivatives, processes for their preparation, pharmaceuticals comprising these compounds, and their use
HUP0104033A3 (en) 1-benzoyl-tetrahydropyridazine derivatives, process for their preparation, their use and medicaments containing the compounds
HUP0001093A3 (en) Oxazolidines as 5-ht2a-antagonists, pharmaceutical compositions containing the same and process for their preparation
HRP950363A2 (en) Novel chemical compound, its preparation and use as a drug
HRP980502B1 (en) Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-10-oles, processes for their preparation and their use as medicaments
HUP9600665A2 (en) Substituted benzothienylpiperazines, their use as medicaments, and processes for their preparation
FI950422L (en) Medicinal products containing new 3-phenylsulfonyl-3,7-diazabicyclo(3,3,1)nonane compounds
HU9802590D0 (en) Sulfonamid-substituted and condensed compounds containing 5-membred ring, their use as medicament and pharmaceutical compositions containing them
HUP0200376A3 (en) Thiaoloindolinone compounds, process for their preparation and pharmaceutical composions containing them and their use
HU9701316D0 (en) Substituted indanylideneacetylguanidines, process for their preparation, their use as medicaments or diagnostic and medicaments containing them
HUP0003962A3 (en) Quinuclidinium compounds process for preparing thereof, pharmaceutical compositions comprising thereof, their use, and their intermediates
HUP0003104A3 (en) Amino-spiropiperidin-quinazoline derivatives, their use, process for their preparation and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
FF Patent granted
MM9K Patent not in force due to non-payment of renewal fees